BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Y, Hsiao H, Wang JC, Liu Y, Wu S. Effectiveness of nalbuphine, a κ‐opioid receptor agonist and μ‐opioid receptor antagonist, in the inhibition of INa , IK(M) , and IK(erg) unlinked to interaction with opioid receptors. Drug Dev Res 2019;80:846-56. [DOI: 10.1002/ddr.21568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Moravcikova L, Moravcik R, Jezova D, Lacinova L, Dremencov E. Delta-opioid receptor-mediated modulation of excitability of individual hippocampal neurons: mechanisms involved. Pharmacol Rep 2021;73:85-101. [PMID: 33161533 DOI: 10.1007/s43440-020-00183-2] [Reference Citation Analysis]
2 Ortiz MI, Cariño-Cortés R, Castañeda-Hernández G. Participation of the opioid receptor - nitric oxide - cGMP - K+ channel pathway in the peripheral antinociceptive effect of nalbuphine and buprenorphine in rats. Can J Physiol Pharmacol 2020;98:753-62. [PMID: 33095677 DOI: 10.1139/cjpp-2020-0104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]